LONG ITCI broken overhead resistance ahead of PDUFA

Long

Intra-Cellular Therapies Inc. (NASDAQ:ITCI)

Updated

NASDAQ:ITCI Intra-Cellular Therapies Inc.

Trend Analysis biotech AMRN AVDL ITCI CVM PFE LONG

trendanalysis biotech amrn avdl itci cvm pfe long

ITCI up 20% on the week and further 30% upside ahead! Looking to test 2019 resistance area around 14.50 ahead of its scheduled PDUFA approval on Dec.27th. TP 2 16.50.

Comment:

Sold at 42.00 thanks for playing

Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.